This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Stemdr Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Innovations of Eun Kyung Song in Sepsis Treatment
Introduction: Eun Kyung Song is a notable inventor based in Jeonju-si, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of sepsis and septic shock. With a total of 2 patents, his work focuses on innovative compositions that can potentially save lives.
Latest Patents: Eun Kyung Song's latest patents include a composition containing an inducer of SIRT1 expression for preventing or treating sepsis or septic shock. This invention is crucial as it can remarkably reduce mortality caused by sepsis or septic shock by decreasing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. The inducer of SIRT1 expression is therefore deemed useful for preventing or treating these critical conditions.
Career Highlights: Eun Kyung Song is currently associated with Stemdr Inc., where he continues to develop groundbreaking solutions in the medical field. His research and inventions have the potential to transform treatment protocols for sepsis, a condition that affects millions worldwide.
Collaborations: Some of his notable coworkers include Myung Kwan Han and Chae Hwa Yoo, who contribute to the collaborative efforts in advancing their research initiatives.
Conclusion: Eun Kyung Song's innovative work in the treatment of sepsis showcases the importance of research and development in medicine. His contributions are paving the way for new therapeutic approaches that could significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile